보존요법과 함께 octreotide 주입을 이용한 수술후 유미흉 치험 2례

Two cases of postoperative chylothorax treated with parenteral octreotide and conservative therapy

  • 최은진 (대구가톨릭대학교 의과대학 소아과학교실) ;
  • 이섭 (대구가톨릭대학교 의과대학 흉부외과학교실)
  • Choi, Eun Jin (Department of Pediatrics, Catholic University of Daegu School of Medicine) ;
  • Lee, Sub (Department of Thoracic and Cardiovascular Surgery, Catholic University of Daegu School of Medicine)
  • 투고 : 2006.12.15
  • 심사 : 2007.01.05
  • 발행 : 2007.03.15

초록

선천성 심장병의 수술후 발생되는 유미흉은 드문 합병증이다. 이는 수분, 전해질 및 영양의 불균형을 초래할 뿐만 아니라 감염에 취약함을 보이기도 한다. 지금까지의 보존요법에 대해 비교적 치료성적이 좋으나 치료에 반응하지 않는 경우에는 수술적 중재가 불가피하다. 저자들은 보존요법과 octreotide 주입을 병행하여 수술적 중재를 피하고 효과적으로 치료한 수술후 발생된 유미흉 2례를 보고하는 바이다.

Chylothorax is a rare complication following cardiac surgery for congenital heart diseases. Although conservative management is successful in the majority of cases, surgical intervention is required in a refractory one. Recently, subcutaneous or intravenous infusion of octreotide has been used as a safe treatment that helps avoiding surgical intervention. Herein, we report two cases of postoperative chylothorax treated with parenteral octreotide and conservative therapy.

키워드

참고문헌

  1. Nguyen DM, Shum-Tim D, Dobell AR, Tchervenkov CI. The management of chylothorax/chylopericardium following pediatric cardiac surgery: a 10-year experience. J Card Surg 1995;10:302-8 https://doi.org/10.1111/j.1540-8191.1995.tb00616.x
  2. Buettiker V, Hug MI, Burger R, Baenziger O. Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 2001;27:1083-6 https://doi.org/10.1007/s001340100959
  3. Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998;66:253-4 https://doi.org/10.1016/S0003-4975(98)00361-0
  4. Rosti L, Bini RM, Chessa M, Butera G, Drago M, Carminati M. The effectiveness of octreotide in the treatment of postoperative chylothorax. Eur J Pediatr 2002;161:149-50 https://doi.org/10.1007/s00431-001-0891-7
  5. Cheung Y, Leung MP, Yip M. Octreotide for treatment of postoperative chylothorax. J Pediatr 2001;139:157-9 https://doi.org/10.1067/mpd.2001.115572
  6. Kelly RF, Shumway SJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 2000;69:1944-5 https://doi.org/10.1016/S0003-4975(00)01279-0
  7. Pratap U, Slavik Z, Ofoe VD, Franklin R. Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 2001;72:1740-2. https://doi.org/10.1016/S0003-4975(01)02581-4
  8. Rasiah SV, Oei J, Lui K. Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health 2004;40: 585-8 https://doi.org/10.1111/j.1440-1754.2004.00471.x
  9. Rosti L, De Battisti F, Butera G, Cirri S, Chessa M, Delogu A, Drago M, Giamberti A, Pome G, Carminati M, Frigiola A. Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 2005;26:440-3 https://doi.org/10.1007/s00246-004-0820-4
  10. Allen EM, van Heeckeren DW, Spector ML, Blumer JL. Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg 1991; 26:1169-74 https://doi.org/10.1016/0022-3468(91)90325-N
  11. Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 2005; 80:1864-71 https://doi.org/10.1016/j.athoracsur.2005.04.048
  12. Nakabayashi H, Sagara H, Usukura N, Yoshimitsu K, Imamura T, Seta T. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes 1981;30:440-5 https://doi.org/10.2337/diab.30.5.440
  13. Grosman I, Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 1990;85:1061-72
  14. Peitersen B, Jakobsen B. Medium chain triglycerides for treatment of spontaneous neonatal chylothorax. Acta Paediatr Scand 1977;66:121-5